1
Clinical Trials associated with Allogeneic adipose derived mesenchymal stem cells(Mayo Clinic)Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)
The purpose of this research is to test an investigational drug called Adipose Mesenchymal Stem Cells (aMSCs) for the treatment of ischemia re-perfusion injury (IRI) in patients that have had a kidney transplant.
100 Clinical Results associated with Allogeneic adipose derived mesenchymal stem cells(Mayo Clinic)
100 Translational Medicine associated with Allogeneic adipose derived mesenchymal stem cells(Mayo Clinic)
100 Patents (Medical) associated with Allogeneic adipose derived mesenchymal stem cells(Mayo Clinic)
100 Deals associated with Allogeneic adipose derived mesenchymal stem cells(Mayo Clinic)